Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia

British Journal of Haematology

Volumn 141, Issue 5, 2008, Pages 736-739

  Lee, Cheng Yeh ^a   Tien, Hwei Fang ^b   Hou, Hsin An ^b   Chou, Wen Chien ^b   Lin, Liang In ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute myeloid leukaemia; Biomarker; Osteopontin; Prognosis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; OSTEOPONTIN; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; BONE MARROW; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; KAPLAN MEIER METHOD; LETTER; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; OSTEOPONTIN; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 43449091604     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07082.x     Document Type: Letter

References (9)

1. Fedarko, N.S., Jain, A., Karadag, A., Van Eman, M.R. Fisher, L.W. (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clinical Cancer Research, 7, 4060 4066.
2. Flamant, S., Kortulewski, T., Dugray, A., Bonnet, M.L., Guillier, M., Guilhot, F., Bourhis, J.H., Vainchenker, W., Roux, D.T.L. Turhan, A.G. (2005) Osteopontin is upregulated by BCR-ABL. Biochemical and Biophysical Research Communications, 333, 1378 1384.
3. Haylock, D.N. Nilsson, S.K. (2006) Osteopontin: a bridge between bone and blood. British Journal of Haematology, 134, 467 474.
4. Lee, C.Y., Tien, H.F., Hu, C.Y., Chou, W.C. Lin, L.I. (2007) Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. British Journal of Cancer, 97, 877 882.
5. Nilsson, S.K., Johnston, H.M., Whitty, G.A., Williams, B., Webb, R.J., Denhardt, D.T., Bertoncello, I., Bendall, L.J., Simmons, P.J. Haylock, D.N. (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 106, 1232 1239.
6. Rangaswami, H., Bulbule, A. Kundu, G.C. (2006) Osteopontin: role in cell signaling and cancer progression. Trends in Cell Biology, 16, 79 87.
7. Rittling, S.R. Chambers, A.F. (2004) Role of osteopontin in tumour progression. British Journal of Cancer, 90, 1877 1881.
8. Standal, T., Hjorth-Hansen, H., Rasmussen, T., Dahl, I.M.S., Lenhoff, S., Brenne, A.T., Seidel, C., Baykov, V., Waage, A., Borset, M., Sundan, A. Hjertner, O. (2004) Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica, 89, 174 182.
9. Stier, S., Ko, Y., Forkert, F., Lutz, C., Neuhaus, T., Grunewald, E., Cheng, T., Dombkowski, D., Calvi, L.M., Rittling, S.R. Scadden, D.T. (2005) Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. Journal of Experimental Medicine, 201, 1781 1791.